Hit discovery to lead optimization of fully human antibodies for your therapeutic development project.
Humanization of hybridoma and other non-human antibodies by rational design and in vitro evolution techniques.
Tailored engineering of antibodies to improve affinity, stability, format or to add new functions (bispecifics and enzyme fusion proteins).
Customized immune or naive antibody gene libraries from human donors or animals.
Rapid in vitro generation of recombinant monoclonal antibodies tailored for your research and diagnostic application in less than 6 weeks.
Identification of novel biomarkers from bacterial pathogens or human cells/tissues for vaccine and diagnostic development.